Orgenesis Inc. EV/FCF

EV/FCF of ORGS for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/FCF growth rates and interactive chart. A valuation metric that measures the enterprise value of a stock compared to its free cash flow. Free cash flow is calculated as operating cash flow - capital expenditures and is a more accurate measure of a company's earning power than net income, as it's not easily manipulated. A low EV/FCF ratio can indicate undervaluation, while a high one might mean the growth expectations around the company are elevated. EV/FCF ratio can be compared to different companies in the same industry or to a company’s own historical valuation.


Highlights and Quick Summary

Current EV/FCF of Orgenesis Inc. is -2.19 (as of December 31, 2021)
  • EV/FCF for the quarter ending March 31, 2022 was -2.93 (a 33.91% increase compared to previous quarter)
  • Year-over-year quarterly EV/FCF increased by 100.11%
  • Annual EV/FCF for 2021 was -2.19 (a 181.74% increase from previous year)
  • Annual EV/FCF for 2020 was -0.78 (a -77.33% decrease from previous year)
  • Annual EV/FCF for 2019 was -3.42 (a 50.07% increase from previous year)
Visit stockrow.com/ORGS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/FCF of Orgenesis Inc.

Most recent EV/FCFof ORGS including historical data for past 10 years.

Interactive Chart of EV/FCF of Orgenesis Inc.

Orgenesis Inc. EV/FCF for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -2.93
2021 -2.19 -1.57 -1.46 -1.54 -2.19
2020 -0.78 -0.77 -1.14 0.84 -0.78
2019 -3.42 -3.21 -2.59 -2.75 -3.42
2018 -2.28 -4.11 -5.61 -12.77 -2.28
2017 -12.05 -8.01 -27.93 -15.04
2016 -15.48 -7.59 -5.49 -1.21 -15.48
2015 0.0

Business Profile of Orgenesis Inc.

Sector: Healthcare
Industry: Biotechnology